Fibroblast Growth Factors/Fibroblast Growth Factor Receptors as Targets for the Development of Anti-Angiogenesis Strategies

By  

Current Pharmaceutical Design, Vol. 13, Iss. 20, 2007-07 ,pp. : 2025-2044

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical Development of Angiogenesis Inhibitors to Vascular Endothelial Growth Factor and Its Receptors as Cancer Therapeutics

By  

Current Cancer Drug Targets, Vol. 2, Iss. 2, 2002-06 ,pp. : 135-156

Bentham Science Publishers

Access to resources Recommend Favorite

Novel peptides targeting the hepatocyte growth factor receptor c-Met for the treatment of cancer

By Michaud Neil R  

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 5, 2005-05 ,pp. : 621-625

Informa Healthcare

Access to resources Recommend Favorite

Antiangiogenic agents targeting vascular endothelial growth factor and its receptors in clinical development

By Sepp-Lorenzino Laura   Thomas Kenneth A  

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 10, 2002-10 ,pp. : 1447-1465

Informa Healthcare

Access to resources Recommend Favorite

Novel Therapeutic Approaches Targeting Vascular Endothelial Growth Factor and its Receptors in Haematological Malignancies

By  

Current Cancer Drug Targets, Vol. 5, Iss. 8, 2005-12 ,pp. : 573-578

Bentham Science Publishers

Access to resources Recommend Favorite